Iovance Biotherapeutics, Inc. (IOVA)
8.07
-0.22
(-2.65%)
USD |
NASDAQ |
Aug 24, 16:00
8.05
-0.02
(-0.25%)
After-Hours: 20:00
Iovance Biotherapeutics Total Liabilities (Quarterly) : 179.49M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 179.49M |
| March 31, 2026 | 203.91M |
| December 31, 2025 | 214.59M |
| September 30, 2025 | 202.66M |
| June 30, 2025 | 208.95M |
| March 31, 2025 | 198.88M |
| December 31, 2024 | 200.02M |
| September 30, 2024 | 217.66M |
| June 30, 2024 | 195.78M |
| March 31, 2024 | 189.81M |
| December 31, 2023 | 195.74M |
| September 30, 2023 | 178.31M |
| June 30, 2023 | 178.72M |
| March 31, 2023 | 157.89M |
| December 31, 2022 | 164.34M |
| September 30, 2022 | 152.19M |
| June 30, 2022 | 138.19M |
| March 31, 2022 | 149.26M |
| December 31, 2021 | 155.67M |
| September 30, 2021 | 130.50M |
| June 30, 2021 | 108.38M |
| March 31, 2021 | 103.14M |
| December 31, 2020 | 111.96M |
| September 30, 2020 | 70.45M |
| June 30, 2020 | 59.26M |
| Date | Value |
|---|---|
| March 31, 2020 | 44.98M |
| December 31, 2019 | 45.68M |
| September 30, 2019 | 40.68M |
| June 30, 2019 | 38.50M |
| March 31, 2019 | 26.57M |
| December 31, 2018 | 14.63M |
| September 30, 2018 | 16.67M |
| June 30, 2018 | 14.18M |
| March 31, 2018 | 14.69M |
| December 31, 2017 | 10.19M |
| September 30, 2017 | 8.529M |
| June 30, 2017 | 8.86M |
| March 31, 2017 | 5.503M |
| December 31, 2016 | 4.968M |
| September 30, 2016 | 3.194M |
| June 30, 2016 | 4.606M |
| March 31, 2016 | 1.83M |
| December 31, 2015 | 1.63M |
| September 30, 2015 | 2.855M |
| June 30, 2015 | 1.866M |
| March 31, 2015 | 1.911M |
| December 31, 2014 | 1.662M |
| September 30, 2014 | 1.259M |
| June 30, 2014 | 1.156M |
| March 31, 2014 | 1.276M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Agenus, Inc. | 378.54M |
| Amgen, Inc. | 83.95B |
| Neurocrine Biosciences, Inc. | 1.666B |
| Anika Therapeutics, Inc. | 46.19M |
| BioCryst Pharmaceuticals, Inc. | 1.012B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 915.53M |
| Shareholders Equity (Quarterly) | 736.04M |
| Debt to Equity Ratio | 0.0625 |
| Current Ratio | 4.345 |
| Net Debt Paydown Yield | 0.08% |